XCRP (Xcorporeal) Current Deferred Revenue: $0.28 Mil (As of Sep. 2009)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Xcorporeal Current Deferred Revenue?

Xcorporeal XCRP -99.00% Current Deferred Revenue is $0.28 Mil as of Sep. 2009.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Xcorporeal's current deferred revenue for the quarter that ended in Sep. 2009 was $0.28 Mil.

Xcorporeal Current Deferred Revenue Related Terms

Xcorporeal Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Xcorporeal's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xcorporeal Current Deferred Revenue Chart

Xcorporeal Annual Data
Trend Feb99 Feb00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.15

Xcorporeal Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.15 0.19 0.26 0.28
What does a Current Deferred Revenue of $0.28 Mil mean?
Xcorporeal (XCRP) has a Current Deferred Revenue of $0.28 Mil as of Sep. 2009. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Xcorporeal and its competitors.
Is Xcorporeal's Current Deferred Revenue too high?
Xcorporeal's current Current Deferred Revenue is $0.28 Mil.
How does Xcorporeal's Current Deferred Revenue compare to MFST and GTHP?
Xcorporeal's Current Deferred Revenue of $0.28 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Devices & Instruments company?
A good Current Deferred Revenue depends on the Medical Devices & Instruments industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Xcorporeal and its competitors. Xcorporeal's current Current Deferred Revenue is $0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xcorporeal stock overvalued right now?
Xcorporeal (XCRP) has a current Current Deferred Revenue of $0.28 Mil. The current Current Deferred Revenue is $0.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Xcorporeal (XCRP), the current Current Deferred Revenue is $0.28 Mil as of Sep. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xcorporeal Business Description

Address 80 Empire Drive, Lake Forest, CA, USA, 92630
Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.